Education
About Us
Working with TipRanks
Follow Us
Tonix Pharmaceuticals (TNXP)
:TNXP
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.09M | $ 7.77M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 2.33M | $ 3.03M | $ -112.09M | $ -92.31M | $ -50.51M |
| Operating Income | $ -136.70M | $ -118.38M | $ -112.09M | $ -92.31M | $ -50.51M |
| EBITDA | $ -71.73M | $ -114.09M | $ -110.84M | $ -92.26M | $ -50.48M |
| Net Income | $ -130.04M | $ -116.66M | $ -116.88M | $ -92.29M | $ -52.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 98.78M | $ 24.95M | $ 120.23M | $ 178.66M | $ 77.07M |
| Total Assets | $ 162.89M | $ 154.46M | $ 225.69M | $ 240.90M | $ 98.18M |
| Total Debt | $ 8.12M | $ 9.81M | $ 760.00K | $ 956.00K | $ 1.31M |
| Net Debt | $ -90.66M | $ -15.13M | $ -119.47M | $ -177.70M | $ -75.76M |
| Total Liabilities | $ 23.33M | $ 48.93M | $ 18.51M | $ 22.18M | $ 10.54M |
| Stockholders' Equity | $ 139.56M | $ 105.53M | $ 207.18M | $ 218.72M | $ 87.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -61.05M | $ -109.90M | $ -146.20M | $ -110.86M | $ -57.13M |
| Operating Cash Flow | $ -60.92M | $ -102.00M | $ -98.05M | $ -75.56M | $ -48.57M |
| Investing Cash Flow | $ -120.00K | $ -29.07M | $ -48.15M | $ -35.31M | $ -8.56M |
| Financing Cash Flow | $ 134.87M | $ 36.52M | $ 87.84M | $ 212.49M | $ 123.11M |